Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
Yuki Gosei Kogyo Co.,Ltd., First Half Ordinary Profit Increases by 76%, July-September Ordinary Profit Turns to Profit
4531 Yuki Gosei Kogyo Co.,Ltd. 【J-GAAP】
Earnings ReportYuki Gosei Kogyo Co.,Ltd. <4531> [TSE-S] announced its financial results after the market closed on October 31st (15:00). The ordinary profit (non-consolidated) for the cumulative second quarter of the fiscal year ending March 2025 (April to September) expanded to 437 million yen, an increase of 75.5% compared to the same period last year. However, The progress rate against the 1.14 billion yen full-year plan was 38.3%, almost the same as the five-year average of 41.2%.
Based on the first-half performance announced by the company and the unchanged full-year plan, our calculation indicates that the ordinary profit for the October to March period (second half) is expected to decrease by 20.2% from the same period last year to 703 million yen.
In the most recent three-month period, from July to September (2Q), the ordinary profit/loss turned to a profit of profit of 108 million yen (compared to a loss of 84 million yen in the same period last year). The operating profit/loss margin drastically improved from -2.4% in the same period last year to 4.5%.
Kabutan News
Actual Results
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Progress Rate vs. First Half | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Apr - Sep, 2022 | 6,302 | 521 | 509 | 388 | 17.8 | 77.1 | Oct 31, 2022 | J-GAAP |
Apr - Sep, 2023 | 5,799 | 238 | 249 | 170 | 7.8 | 22.0 | Oct 31, 2023 | J-GAAP |
Apr - Sep, 2024 | 7,197 | 484 | 437 | 366 | 16.8 | 38.3 | Oct 31, 2024 | J-GAAP |
YoY | +24.1% | +103.4% | +75.5% | +115.3% | +115.2% |
First Half Results vs. Previous Guidance
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Apr - Sep, 2024 Guidance | ー | ー | ー | ー | - | 0 | May 15, 2024 | J-GAAP |
Apr - Sep, 2024 Results | 7,197 | 484 | 437 | 366 | 16.8 | 0 | Oct 31, 2024 | J-GAAP |
Revision Rate | - | - | - | - | - |
Current Period Guidance
Second Half Results
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Oct - Mar, 2023 | 7,133 | 887 | 881 | 606 | 27.8 | 8 | May 15, 2024 | J-GAAP |
Oct - Mar, 2024 Guidance | 6,803 | 671 | 703 | 434 | 20.1 | 9 | Oct 31, 2024 | J-GAAP |
YoY | -4.6% | -24.4% | -20.2% | -28.4% | -27.5% |
Current Period Guidance
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Mar, 2023 | 12,839 | 897 | 660 | 556 | 25.5 | 7 | May 15, 2023 | J-GAAP |
Mar, 2024 | 12,932 | 1,125 | 1,130 | 776 | 35.6 | 8 | May 15, 2024 | J-GAAP |
Mar, 2025 Guidance | 14,000 | 1,155 | 1,140 | 800 | 37.1 | 9 | May 15, 2024 | J-GAAP |
YoY | +8.3% | +2.7% | +0.9% | +3.1% | +4.4% |
Quarterly Results
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Operating Profit Margin | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Jul - Sep, 2023 | 2,858 | -70 | -84 | -62 | -2.9 | -2.4 | Oct 31, 2023 | J-GAAP |
Oct - Dec, 2023 | 3,126 | 249 | 236 | 186 | 8.5 | 8.0 | Jan 31, 2024 | J-GAAP |
Jan - Mar, 2024 | 4,007 | 638 | 645 | 420 | 19.3 | 15.9 | May 15, 2024 | J-GAAP |
Apr - Jun, 2024 | 3,263 | 308 | 329 | 284 | 13.0 | 9.4 | Jul 31, 2024 | J-GAAP |
Jul - Sep, 2024 | 3,934 | 176 | 108 | 82 | 3.8 | 4.5 | Oct 31, 2024 | J-GAAP |
YoY | +37.6% | - | - | - | - |
Related Articles
Takeda Pharmaceutical Company Limited, The Current Fiscal Year Net Income Revised Upward by 17%
TAKAGI SEIKO CORPORATION, The Current Fiscal Year Ordinary Profit Revised Downward to an Unexpected 45% Decrease
Hokkaido Electric Power Company, Incorporated, First Half Ordinary Profit Decreases by 28%, Exceeds Full-Year Plan
YELLOW HAT LTD., First Half Ordinary Profit Revised Downward to an Unexpected 2%Decrease
NIKKI CO.,LTD., First Half Ordinary Profit Decreases by 30%, Exceeds Full-Year Plan
NIPPON CHEMIPHAR CO., LTD., First Half Ordinary Profit Turns to Loss, July-September Ordinary Profit Loss Widens
Japan Investment Adviser Co.,Ltd., The Current Fiscal Year Ordinary Profit Revised Downward by 8%
TOMOKU CO.,LTD., First Half Ordinary Profit Decreases by 14%, July-September Ordinary Profit Decreases by 21%
I-NET CORP., First Half Ordinary Profit Decreases by 36%, July-September Ordinary Profit Decreases by 16%
Infomart Corporation, January-September (Third Quarter Cumulative) Ordinary Profit Increases by 21%, July-September Ordinary Profit Increases by 51%